Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats

Endocrine Journal

Volumn 46, Issue 5, 1999, Pages 723-730

  Oshida, Yoshiharu ^a   Kako, Mami ^a   Nakai, Naoya ^a   Shimomura, Yoshiharu ^b   Li, Ling ^a   Sato, Juichi ^c   Ohsawa, Isao ^a   Sato, Yuzo ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

3 Hydroxyacyl CoA dehydrogenase; Glycogen; Insulin sensitivity; Pyruvate dehydrogenase complex; Troglitazone

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; GLYCOGEN; INSULIN; PYRUVATE DEHYDROGENASE; TROGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; ENZYME ACTIVITY; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOGEN MUSCLE LEVEL; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT;

EID: 0032710374     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.46.723     Document Type: Article

References (36)

1. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15: 318-368.
2. Yki-Jarvinen H (1995) Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 38: 1378-1388.
3. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595-1607.
4. 2max. J Appl Physiol 66: 2206-2210.
5. Yamanouchi K, Shinozaki T, Chikada K, Nishikawa T, Ito K, Shimizu S, Ozawa N, Maeno H, Kato K, Oshida Y, Sato Y (1995) Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care 18: 775-778.
6. Kamiya A, Ohsawa I, Fujii T, Sato J, Oshida Y, Yamanouchi Y, Sato Y(1995) A clinical survey on the compliance of exercise therapy for diabetic patients. Diabetes Res Clin Pract 27: 141-145.
7. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H (1988) Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37: 1549-1558.
8. Lee M-K, Miles PDG, Khoursheed M, Gao K-M, Moossa AR, Olefsky JM (1994) Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes 43: 1435-1439.
9. Bahr M, Spelleken M, von Holtey M, Kiehn R, Eckel J (1996) Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes. Diabetologia 39: 766-774.
10. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J (1994) Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331: 1188-1193.
11. Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T (1996) Effect of combination therapy of troglitazone and sulfonylureas in patients with type 2 diabetes who were poorly controlled by sulfonylurea therapy alone, Diabetic Med 13: 365-370.
12. Kumar S, Boulton AJM, Beck-Nielsen H, Berthezene F, Muggeo M, Rersson B, Spinas GA, Donogue S, Lettis S, Stewart-Long P (1996) Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Diabetologia 39: 701-709.
13. Bader S, Kiehn R, Haring HU (1993) Effect of CS-045 on the activity of insulin-receptor kinase in the skeletal muscle of insulin-resistant Zucker rats. Diabetes and Stoffwechsel 1: 55-61.
14. Yang W-P, Oshida Y, Wu W, Sato J, Ohsawa I, Sato Y (1995) Effect of daily voluntary running on in vivo insulin action in rat skeletal muscle and adipose tissue as determined by the microdialysis technique. Int J Sports Med 16: 99-104.
15. Wu W, Oshida Y, Yang W-P, Li L, Ohsawa I, Sato J, Johansson B-L, Wahren J, Sato Y (1996) Effect of C-peptide administration on whole body glucose utilization in STZ-induced diabetic rats. Acta Physiol Scand 157: 253-258.
16. Nakai N, Collier GR, Sato Y, Oshida Y, Fujitsuka N, Shimomura Y (1997) Activities of liver pyruvate dehydrogenase complex and 3-hydroxyacyle-CoA dehydrogenase in sand rat (Psammomys Obesus). Life Sci 60: 51-55.
17. Nakai N, Sato Y, Oshida Y, Yoshimura A, Fujitsuka N, Sugiyama S, Shimomura Y (1997) Effects of aging on the activities of pyruvate dehydrogenase complex and its kinase in rat heart. Life Sci 60: 2309-2314.
18. Bradshaw RA, Noyes BE (1975) L-3-hydroxyacyl coenzyme A dehydrogenase from pig heart muscle. Method Enzymol 105: 122-128.
19. Nakai N, Shimomura Y, Ohsaki N, Sato J, Oshida Y, Ohsawa I, Fujitsuka N, Sato Y (1996) Exercise training prevents maturation-induced decrease in insulin sensitivity. J Appl Physiol 80: 1963-1967.
20. Johnson HD, Ward MW, Kibler HH (1966) Heat and aging effects on thyroid function of male rats. J Appl Physiol 21: 689-694.
21. Sherman WM, Katz AL, Cutler CL, Ivy JL (1988) Glucose transport: locus of muscle insulin resistance in obese Zucker rats. Am J Physiol 255: E374-E382.
22. Brozinick Jr JT, Etgen Jr GJ, Yaspelkis III BB, Kang HY, Ivy JL (1993) Effects of exercise training on muscle GLUT-4 protein content and translocation in obese Zucker rats. Am J Physiol 265: E419-E427.
23. Etgen Jr GJ, Wilson CM, Jensen J, Cushman SW, Ivy JL (1996) Glucose transport and cell surface GLUT-4 protein in skeletal muscle of the obese Zucker rats. Am J Physiol 271: E294-E301.
24. Ciaraldi TP, Gilmore A, Olefsky JM, Goldberg M, Heidenreich KA (1990) In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism 39: 1056-1062.
25. Ohsumi J, Sakakibara S, Yamaguchi J, Miyadai K, Koshioka S, Fujiwara T, Horikoshi H (1994) Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-LI cells. Endocrinology 135: 2279-2282.
26. Holman C, Lorenz K, Colca JR (1991) Glucose transport deficiency in diabetic animals is corrected by treatment with the oral anti-hyperglycemic agent pioglitazone. Endocrinology 129: 1915-1925.
27. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkinson WO, Willson TM, Kliewer SA (1995) An anti-diabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270: 12953-12956.
28. De Vos P, Lefebvre AM, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J (1996) Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated γ. J Clin Invest 98: 1004-1009.
29. Okuno A, Tamemoto H, Tobe K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T (1998) Troglitazone in-creases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101: 1354-1361.
30. Okuno A, Ikeda K, Shiota M, Fujiwara T, Yoshioka S, Sugano T, Horikoshi H (1997) Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb. Metabolism 46: 716-721.
31. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP (1981) The effect of insulin on the disposal of intravenous glucose. Diabetes 30: 1000-1007.
32. Fuller SJ, Randle PJ (1984) Reversible phosphorylation of pyruvate dehydrogenase in rat skeletal-muscle mitochondria. Effects of starvation and diabetes. Biochem J 219: 635-646.
33. Sugden MC, Holness MJ (1989) Effects of re-feeding after prolonged starvation on pyruvate dehydrogenase activities in heart, diaphragm, and skeletal muscle of the rat. Biochem J 262: 669-672.
34. Feldhoff PW, Arnold J, Oesterling B, Vary TC (1993) Insulin-induced activation of pyruvate dehydrogenase complex in skeletal muscle of diabetic rats. Metabolism 42: 615-623.
35. Inoue I, Takahashi K, Katayama S, Harada Y, Negishi K, Itabashi A, Ishii J (1995) Effect of troglitazone and bezafibrate on glucose tolerance, liver glycogen synthase activity, and β-oxidation in fructose-fed rats. Metabolism 44: 1626-1630.
36. Yoshioka S, Nishino H, Shiraki T, Koike H, Okuno A, Wada M, Fujiwara T, Horikoshi H (1993) Anti-hypertensive effects of CS-045 treatment on obese Zucker rats. Metabolism. 42: 75-80.